• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种核糖核酸酶同系物还原展开途径的差异

Dissimilarity in the reductive unfolding pathways of two ribonuclease homologues.

作者信息

Narayan Mahesh, Xu Guoqiang, Ripoll Daniel R, Zhai Huili, Breuker Kathrin, Wanjalla Celestine, Leung Howard J, Navon Amiel, Welker Ervin, McLafferty Fred W, Scheraga Harold A

机构信息

Baker Laboratory of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853-1301, USA.

出版信息

J Mol Biol. 2004 May 7;338(4):795-809. doi: 10.1016/j.jmb.2004.03.014.

DOI:10.1016/j.jmb.2004.03.014
PMID:15099746
Abstract

Using DTT(red) as the reducing agent, the kinetics of the reductive unfolding of onconase, a frog ribonuclease, has been examined. An intermediate containing three disulfides, Ir, that is formed rapidly in the reductive pathway, is more resistant to further reduction than the parent molecule, indicating that the remaining disulfides in onconase are less accessible to DTT(red). Disulfide-bond mapping of Ir indicated that it is a single species lacking the (30-75) disulfide bond. The reductive unfolding pattern of onconase is consistent with an analysis of the exposed surface area of the cysteine sulfur atoms in the (30-75) disulfide bond, which reveals that these atoms are about four- and sevenfold, respectively, more exposed than those in the next two maximally exposed disulfides. By contrast, in the reductive unfolding of the homologue, RNase A, there are two intermediates, arising from the reduction of the (40-95) and (65-72) disulfide bonds, which takes place in parallel, and on a much longer time-scale, compared to the initial reduction of onconase; this behavior is consistent with the almost equally exposed surface areas of the cysteine sulfur atoms that form the (40-95) and (65-72) disulfide bonds in RNase A and the fourfold more exposed cysteine sulfur atoms of the (30-75) disulfide bond in onconase. Analysis and in silico mutation of the residues around the (40-95) disulfide bond in RNase A, which is analogous to the (30-75) disulfide bond of onconase, reveal that the side-chain of tyrosine 92 of RNase A, a highly conserved residue among mammalian pancreatic ribonucleases, lies atop the (40-95) disulfide bond, resulting in a shielding of the corresponding sulfur atoms from the solvent; such burial of the (30-75) sulfur atoms is absent from onconase, due to the replacement of Tyr92 by Arg73, which is situated away from the (30-75) disulfide bond and into the solvent, resulting in the large exposed surface-area of the cysteine sulfur atoms forming this bond. Removal of Tyr92 from RNase A resulted in the relatively rapid reduction of the mutant to form a single intermediate (des [40-95] Y92A), i.e. it resulted in an onconase-like reductive unfolding behavior. The reduction of the P93A mutant of RNase A proceeds through a single intermediate, the des [40-95] P93A species, as in onconase. Although mutation of Pro93 to Ala does not increase the exposed surface area of the (40-95) cysteine sulfur atoms, structural analysis of the mutant reveals that there is greater flexibility in the (40-95) disulfide bond compared to the (65-72) disulfide bond that may make the (40-95) disulfide bond much easier to expose, consistent with the reductive unfolding pathway and kinetics of P93A. Mutation of Tyr92 to Phe92 in RNase A has no effect on its reductive unfolding pathway, suggesting that the hydrogen bond between the hydroxyl group of Tyr92 and the carbonyl group of Lys37 has no impact on the local unfolding free energy required to expose the (40-95) disulfide bond. Thus, these data shed light on the differences between the reductive unfolding pathways of the two homologous proteins and provide a structural basis for the origin of this difference.

摘要

以二硫苏糖醇(红色)作为还原剂,研究了蛙核糖核酸酶癌酶还原解折叠的动力学。在还原途径中迅速形成的一种含有三个二硫键的中间体Ir,比亲本分子更耐进一步还原,这表明癌酶中其余的二硫键对二硫苏糖醇(红色)的可及性较低。Ir的二硫键图谱表明它是一种缺乏(30 - 75)二硫键的单一物种。癌酶的还原解折叠模式与对(30 - 75)二硫键中半胱氨酸硫原子暴露表面积的分析一致,该分析表明这些原子的暴露程度分别比接下来两个最大暴露的二硫键中的原子高约四倍和七倍。相比之下,在同源物核糖核酸酶A的还原解折叠过程中,有两个中间体,由(40 - 95)和(65 - 72)二硫键的还原产生,这两个过程并行发生,且与癌酶的初始还原相比,时间尺度长得多;这种行为与核糖核酸酶A中形成(40 - 95)和(65 - 72)二硫键的半胱氨酸硫原子几乎相同的暴露表面积以及癌酶中(30 - 75)二硫键中半胱氨酸硫原子大四倍的暴露程度一致。对核糖核酸酶A中与癌酶的(30 - 75)二硫键类似的(40 - 95)二硫键周围残基进行分析和计算机模拟突变,结果表明核糖核酸酶A的酪氨酸92(哺乳动物胰腺核糖核酸酶中高度保守的残基)的侧链位于(40 - 95)二硫键之上,导致相应的硫原子被溶剂屏蔽;癌酶中不存在(30 - 75)硫原子的这种埋藏情况,因为73位的精氨酸取代了92位的酪氨酸,该精氨酸远离(30 - 75)二硫键并伸向溶剂,导致形成该键的半胱氨酸硫原子具有较大的暴露表面积。从核糖核酸酶A中去除酪氨酸92导致突变体相对快速地还原形成单一中间体(去[40 - 95] Y92A),即它导致了类似癌酶的还原解折叠行为。核糖核酸酶A的P93A突变体的还原过程通过单一中间体去[40 - 95] P93A物种进行,与癌酶情况相同。尽管将脯氨酸93突变为丙氨酸并没有增加(40 - 95)半胱氨酸硫原子的暴露表面积,但对该突变体的结构分析表明,与(65 - 72)二硫键相比,(40 - 95)二硫键具有更大的灵活性,这可能使(40 - 95)二硫键更容易暴露,这与P93A的还原解折叠途径和动力学一致。将核糖核酸酶A中的酪氨酸92突变为苯丙氨酸92对其还原解折叠途径没有影响,这表明酪氨酸92的羟基与赖氨酸37的羰基之间的氢键对暴露(40 - 95)二硫键所需的局部解折叠自由能没有影响。因此,这些数据揭示了这两种同源蛋白质还原解折叠途径之间的差异,并为这种差异的起源提供了结构基础。

相似文献

1
Dissimilarity in the reductive unfolding pathways of two ribonuclease homologues.两种核糖核酸酶同系物还原展开途径的差异
J Mol Biol. 2004 May 7;338(4):795-809. doi: 10.1016/j.jmb.2004.03.014.
2
Characterization of the fast-forming intermediate, des [30-75], in the reductive unfolding of onconase.在抗癌酶还原解折叠过程中快速形成的中间体des [30-75]的表征
Biochemistry. 2004 Mar 23;43(11):3246-54. doi: 10.1021/bi036215d.
3
Conformational unfolding studies of three-disulfide mutants of bovine pancreatic ribonuclease A and the coupling of proline isomerization to disulfide redox reactions.牛胰核糖核酸酶A的三二硫键突变体的构象展开研究以及脯氨酸异构化与二硫键氧化还原反应的偶联
Biochemistry. 1999 Mar 2;38(9):2805-15. doi: 10.1021/bi982593k.
4
Effect of mutation of proline 93 on redox unfolding/folding of bovine pancreatic ribonuclease A.脯氨酸93突变对牛胰核糖核酸酶A氧化还原去折叠/折叠的影响。
Biochemistry. 2001 Jul 24;40(29):8536-41. doi: 10.1021/bi010692j.
5
A localized specific interaction alters the unfolding pathways of structural homologues.局部特异性相互作用改变了结构同源物的解折叠途径。
J Am Chem Soc. 2006 Feb 1;128(4):1204-13. doi: 10.1021/ja055313e.
6
Dissimilarity in the oxidative folding of onconase and ribonuclease A, two structural homologues.癌酶与核糖核酸酶A(两种结构同源物)氧化折叠的差异
Protein Eng Des Sel. 2008 Apr;21(4):223-31. doi: 10.1093/protein/gzm093. Epub 2008 Jan 31.
7
Simultaneous characterization of the reductive unfolding pathways of RNase B isoforms by top-down mass spectrometry.通过自上而下的质谱法同时表征核糖核酸酶B同工型的还原解折叠途径。
Chem Biol. 2004 Apr;11(4):517-24. doi: 10.1016/j.chembiol.2004.03.020.
8
Structural characterization of a three-disulfide intermediate of ribonuclease A involved in both the folding and unfolding pathways.核糖核酸酶A一种三硫键中间体的结构表征,该中间体参与折叠和去折叠途径。
Biochemistry. 1994 Aug 30;33(34):10437-49. doi: 10.1021/bi00200a027.
9
Regeneration of three-disulfide mutants of bovine pancreatic ribonuclease A missing the 65-72 disulfide bond: characterization of a minor folding pathway of ribonuclease A and kinetic roles of Cys65 and Cys72.缺失65-72二硫键的牛胰核糖核酸酶A的三二硫键突变体的再生:核糖核酸酶A一条次要折叠途径的表征以及半胱氨酸65和半胱氨酸72的动力学作用
Biochemistry. 1998 Mar 31;37(13):4490-501. doi: 10.1021/bi9725327.
10
Contribution of the C30/C75 disulfide bond to the biological properties of onconase.C30/C75二硫键对昂科纳酶生物学特性的贡献。
Biol Chem. 2008 Aug;389(8):1127-36. doi: 10.1515/BC.2008.114.

引用本文的文献

1
A Humanized Anti-CD22-Onconase Antibody-Drug Conjugate Mediates Highly Potent Destruction of Targeted Tumor Cells.一种人源化抗 CD22-奥曲肽抗体药物偶联物介导高效靶向肿瘤细胞的杀伤作用。
J Immunol Res. 2015;2015:561814. doi: 10.1155/2015/561814. Epub 2015 Oct 28.
2
Identification of formation of initial native structure in onconase from an unfolded state.鉴定来自非折叠状态的伴刀豆球蛋白 A 的初始天然结构的形成。
Biochemistry. 2012 Jan 10;51(1):521-32. doi: 10.1021/bi201168d. Epub 2011 Dec 14.
3
Ribonucleases as potential modalities in anticancer therapy.
核糖核酸酶作为抗癌疗法的潜在手段。
Eur J Pharmacol. 2009 Dec 25;625(1-3):181-9. doi: 10.1016/j.ejphar.2009.06.067. Epub 2009 Oct 14.
4
Effects of tyrosine mutations on the conformational and oxidative folding of ribonuclease a: a comparative study.酪氨酸突变对核糖核酸酶a构象和氧化折叠的影响:一项比较研究。
Biochemistry. 2009 May 12;48(18):3887-93. doi: 10.1021/bi802362t.
5
Oxidative folding pathway of onconase, a ribonuclease homologue: insight into oxidative folding mechanisms from a study of two homologues.核糖核酸酶同系物癌胚胰腺蛋白酶的氧化折叠途径:通过对两种同系物的研究洞察氧化折叠机制
Biochemistry. 2009 Mar 31;48(12):2740-51. doi: 10.1021/bi802327j.
6
Onconase and amphinase, the antitumor ribonucleases from Rana pipiens oocytes.豹蛙卵母细胞中的抗肿瘤核糖核酸酶——癌抑素和两栖酶。
Curr Pharm Biotechnol. 2008 Jun;9(3):215-25. doi: 10.2174/138920108784567245.
7
Dissimilarity in the oxidative folding of onconase and ribonuclease A, two structural homologues.癌酶与核糖核酸酶A(两种结构同源物)氧化折叠的差异
Protein Eng Des Sel. 2008 Apr;21(4):223-31. doi: 10.1093/protein/gzm093. Epub 2008 Jan 31.
8
Oxidative folding and N-terminal cyclization of onconase.癌酶的氧化折叠与N端环化
Biochemistry. 2007 May 8;46(18):5485-93. doi: 10.1021/bi602495a. Epub 2007 Apr 18.
9
A localized specific interaction alters the unfolding pathways of structural homologues.局部特异性相互作用改变了结构同源物的解折叠途径。
J Am Chem Soc. 2006 Feb 1;128(4):1204-13. doi: 10.1021/ja055313e.
10
Stepwise deamidation of ribonuclease A at five sites determined by top down mass spectrometry.通过自上而下的质谱法在五个位点对核糖核酸酶A进行逐步脱酰胺作用。
Biochemistry. 2006 Jan 24;45(3):987-92. doi: 10.1021/bi0517584.